CompletedPhase 4NCT03497689
EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension
Studying Idiopathic pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- United Therapeutics
- Principal Investigator
- Chad E Miller, MDPiedmont Healthcare Pulmonary and Critical Care Research
- Intervention
- Intravenous/Subcutaneous Treprostinil; Oral Treprostinil(drug)
- Enrollment
- 36 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2019 – 2022
Study locations (11)
- University of California San Francisco - Fresno, Fresno, California, United States
- Harbor-UCLA Medical Center, Torrance, California, United States
- Florida Hospital, Orlando, Florida, United States
- Piedmont Healthcare Pulmonary and Critical Care Research, Austell, Georgia, United States
- St. Vincent Medical Group, Indianapolis, Indiana, United States
- University of Nebraska Medical Center, Omaha, Nebraska, United States
- University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
- University of Cincinnati Health, Cincinnati, Ohio, United States
- The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
- Integris Baptist Medical Center, Oklahoma City, Oklahoma, United States
- UPMC Presbytarian Hospital, Pittsburgh, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03497689 on ClinicalTrials.govOther trials for Idiopathic pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT06829589Retrieval of Economic Incentives and Information on Quality-of-care Indicators in Primary CareFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
- RECRUITINGNANCT06605794FreeFlow Percutaneous Atrial Septal Shunt for IPAHShanghai Zhongshan Hospital
- ACTIVE NOT RECRUITINGNCT05723185Primary Care-Hospital Embedding: a Prospective, Multicentric, Observational StudyRovere Querini Patrizia
- RECRUITINGNANCT05584722Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible IndividualsVanderbilt University Medical Center
- ACTIVE NOT RECRUITINGPHASE2NCT05679570Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)International University of Health and Welfare
- RECRUITINGNCT04756076Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension PatientsJiapeng Huang
See all trials for Idiopathic pulmonary arterial hypertension →